Privigen
STN: 125201
Proper Name: Immune Globulin Intravenous (Human), 10% Liquid
Tradename: Privigen
Manufacturer: CSL Behring AG, License #1766
Indication:
For the treatment of:
- Primary humoral immunodeficiency;
- Chronic immune thrombocytopenic purpura (ITP) in patients age 15 years and older;
- Chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.
Product Information
Supporting Documents
- September 14, 2017 SBRA-Privigen
- September 14, 2017 Approval Letter - Privigen
- Supporting Documents older than three years - Privigen